— Know what they know.
Not Investment Advice

HROW NASDAQ

Harrow Health, Inc.
1W: +6.8% 1M: -15.8% 3M: -36.6% YTD: -34.0% 1Y: +17.4% 3Y: +56.6% 5Y: +267.0%
$33.00
+0.04 (+0.12%)
 
Weekly Expected Move ±12.7%
$23 $27 $31 $35 $39
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Sell · Power 34 · $1.2B mcap · 28M float · 3.04% daily turnover · Short 58% of daily vol

📊 Key Metrics

TTM
$269M
Revenue
+26.2% YoY
$-15M
Net Income
+31.0% YoY
$14M
Free Cash Flow
+139.0% YoY
61.2%
Gross Margin
-50.0%
Op. Margin
-62.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-24.5%
ROA-3.8%
ROIC9.6%

Valuation

P/E-82.1
P/B42.8
EV/EBITDA37.4

Leverage

Debt/Equity4.80
Current Ratio2.20
Interest Cov.0.9x

Quality Scores

Piotroski F6/9
Altman Z2.91
Beneish M-2.84

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms